JESSICA ALLYN: Open Payments
NPI 1407208788 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,968 in 216 payments from 34 companies in 2025. Trend: 2023 $4,898 · 2024 $4,399 · 2025 $3,968
Food & beverage: $3,968
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 31 | $545 |
| ABBVIE INC. | 19 | $315 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $239 |
| Lundbeck LLC | 8 | $227 |
| Janssen Pharmaceuticals, Inc | 9 | $224 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $206 |
| Novo Nordisk Inc | 14 | $201 |
| PFIZER INC. | 12 | $201 |
| Amgen Inc. | 16 | $189 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
Products named: REXULTI, XIFAXAN, Auvelity, SPRAVATO, Kerendia, Sunosi, NURTEC ODT, CAPLYTA.
Industry payments across NC — which companies pay providers there.
